In this series of webinars, explore the latest trends in biopharmaceutical research and development. Discover the techniques and technologies helping researchers improve tumor-specific immunotherapies, simplify complex characterization of large molecules, optimize oligonucleotide analysis, ensure regulatory compliance and data integrity, and much more.
Register by clicking on the live events below to hear from biopharma experts. Ask the speakers your questions in the live Q&A sessions following each presentation. Plus, check out a selection of our on-demand webinars and download related resources to supplement your own research.
Now available on demand
Dr. Jim Arndt, from MOBILion, and Dr. Jeffrey Agar, Associate Professor at Barnett Institute Northeastern University, will discuss the benefits of HRIM-MS for enhancing structural characterization of large molecule therapeutics, while increasing throughput and reducing reliance on LC-based methods.
Thursday, May 20, at 16:00 BST / 17:00 CEST / 11:00 EDT / 8:00 PDT
T cell exhaustion is recognized as a major challenge in the development of immuno-oncology therapies. It describes the loss of effector function due to chronic antigen exposure, and often occurs within the tumor microenvironment, impairing the ability of T cells to eradicate cancerous cells effectively. In this webinar, gain unique insights into how bispecific T cell engager (BiTE) antibodies in an immune cell killing assay affect T cell exhaustion; explore the influence of target cells on CAR-T cell exhaustion; and learn how to use an advanced flow cytometry platform to quantify T cell exhaustion phenotypes and cytokine release.
Friday, May 21, at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Learn how advanced security features and built-in technical controls minimize security risks when applied to workflows for the analysis of intact proteins, protein digests and released glycans, by enabling setup of user roles, user permissions, audit trails, checksums, and secure content management across all software modules.
Tuesday, May 25, at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Dr. Stephanie Ling, Associate Principal Scientist at AstraZeneca, will explore how the integration of Imaging Mass Cytometry™ (IMC™) with other established molecular imaging modalities, including histology and mass spectrometry imaging, can enable insight into the biological complexity of tissues and pathophysiological processes.
Friday, June, 4, at 13:00 BST / 14:00 CEST / 08:00 EDT / 05:00 PDT
SVAR Life Sciences' Product Managers, Therese Segerstein, and Ali Qamar, will explain how functional assays can be used in safe and compliant biopharmaceutical development. They will focus on functional platforms for complement assessment and cell-based solutions for measurement and quantification of drug potency, detection of neutralizing antibodies (NAbs), and assessment of immunogenicity.
Friday, June 4, at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Ensuring high-quality oligonucleotides for therapeutic applications relies on robust analytical methods. In this webinar, hear from principal scientist Dr. Brook Koshel as she discusses method development considerations when selecting an appropriate ion-pairing agent. She will also share tips and tricks for developing efficient methods for ion-pair reversed-phase (IP-RP) analysis of oligonucleotides.
Register for the Biopharmaceuticals Webinar Series here>>